Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multi-centre randomised controlled trial

Chris Nutting; James Morden; K Harrington; Teresa  Guerrero-Urbano; SA Bhide; A Miah; Kate Newbold; Mary Anne  Tanay; Sarah Jefferies; Roger A'Hern; Mark Sydenham; Marie A Emson; Emma Hall

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multi-centre randomised controlled trial

Chris Nutting, James Morden, K Harrington, Teresa Guerrero-Urbano, SA Bhide, A Miah, Kate Newbold, Mary Anne Tanay, Sarah Jefferies, Roger A'Hern, Mark Sydenham, Marie A Emson, Emma Hall

Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care

Research output: Contribution to journal › Article › peer-review

1385 Citations (Scopus)

Original language	English
Pages (from-to)	127
Number of pages	136
Journal	The Lancet Oncology
Volume	12
Issue number	2
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70290-4/fulltext

Cite this

Nutting, C., Morden, J., Harrington, K., Guerrero-Urbano, T., Bhide, SA., Miah, A., Newbold, K., Tanay, M. A., Jefferies, S., A'Hern, R., Sydenham, M., Emson, M. A., & Hall, E. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multi-centre randomised controlled trial. The Lancet Oncology, 12(2), 127. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70290-4/fulltext

@article{6ee3c000020346b58eff0e133720b8b1,

title = "Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multi-centre randomised controlled trial",

author = "Chris Nutting and James Morden and K Harrington and Teresa Guerrero-Urbano and SA Bhide and A Miah and Kate Newbold and Tanay, {Mary Anne} and Sarah Jefferies and Roger A'Hern and Mark Sydenham and Emson, {Marie A} and Emma Hall",

year = "2011",

language = "English",

volume = "12",

pages = "127",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

Nutting, C, Morden, J, Harrington, K, Guerrero-Urbano, T, Bhide, SA, Miah, A, Newbold, K, Tanay, MA, Jefferies, S, A'Hern, R, Sydenham, M, Emson, MA & Hall, E 2011, 'Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multi-centre randomised controlled trial', The Lancet Oncology, vol. 12, no. 2, pp. 127. <https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70290-4/fulltext>

TY - JOUR

T1 - Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multi-centre randomised controlled trial

AU - Nutting, Chris

AU - Morden, James

AU - Harrington, K

AU - Guerrero-Urbano, Teresa

AU - Bhide, SA

AU - Miah, A

AU - Newbold, Kate

AU - Tanay, Mary Anne

AU - Jefferies, Sarah

AU - A'Hern, Roger

AU - Sydenham, Mark

AU - Emson, Marie A

AU - Hall, Emma

PY - 2011

Y1 - 2011

M3 - Article

SN - 1470-2045

VL - 12

SP - 127

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -